Garrison Bradford & Associates’s Biocept, Inc. BIOC Stock Holding History

Garrison Bradford & Associates’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2	Closed	-$3K	–	87
2018 Q2	$3K	Hold	2	–	–	﹤0.01%	86
2018 Q1	$5K	Hold	2	–	–	﹤0.01%	83
2017 Q4	$11K	Sell	2 -1	-33%	-$7.91K	0.01%	86
2017 Q3	$31K	Hold	3	–	–	0.03%	82
2017 Q2	$35K	Hold	3	–	–	0.03%	84
2017 Q1	$55K	Hold	3	–	–	0.05%	83
2016 Q4	$20K	Sell	3 -1	-25%	-$8.36K	0.02%	85
2016 Q3	$59K	Hold	4	–	–	0.06%	85
2016 Q2	$75K	Hold	4	–	–	0.07%	83
2016 Q1	$149K	Hold	4	–	–	0.17%	62
2015 Q4	$160K	Sell	4 -1	-20%	-$53.1K	0.18%	66
2015 Q3	$315K	Hold	5	–	–	0.35%	55
2015 Q2	$349K	Hold	5	–	–	0.34%	60
2015 Q1	$301K	Hold	5	–	–	0.28%	65
2014 Q4	$333K	Sell	5 -1	-17%	-$80.6K	0.3%	68
2014 Q3	$366K	Hold	6	–	–	0.37%	61
2014 Q2	$923K	Hold	6	–	–	0.86%	28
2014 Q1	$1.15M	Buy	+6	New	+$1.36M	1.11%	22

Other funds holding BIOC

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Garrison Bradford & Associates's BIOC Position: Q3 2018 in Review

Garrison Bradford & Associates sold out of Biocept, Inc. (BIOC) in Q3 2018, closing a stake of 2 shares — an estimated $3K sold.

Garrison Bradford & Associates first reported a position in BIOC in Q1 2014 and held it in 18 quarters. The position peaked at $1.15M in Q1 2014. 8 funds tracked by Wall St. Rank hold BIOC as of Q3 2018.

Garrison Bradford & Associates reported no remaining Biocept, Inc. position as of Q3 2018 after selling out during the quarter.
Garrison Bradford & Associates sold 2 Biocept, Inc. shares in Q3 2018, an estimated $3K.
Garrison Bradford & Associates first reported a position in Biocept, Inc. in Q1 2014 and held it in 18 quarters.
Garrison Bradford & Associates's Biocept, Inc. position peaked at $1.15M in Q1 2014.
8 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2018.

Based on Garrison Bradford & Associates's 13F filing for Q3 2018, filed 2 Nov 2018.